clinical trial retatrutide A New Obesity Drug Delivered Surgery-Level Weight Loss in Trials VisualAbstract: Retatrutide reduces body weight

SGLT-2 is expressed in the proximal tubule and mediates re-absorption of ~90% of filtered glucose Rx of Heart Failure : There is accumulating evidence for numerous additional mechanisms of action separate from SGLT2 inhibition that appear to underlie the ability of gliflozins to produce additional effects associated with favorable outcomes, such as in the reduction of mortality and CV events in patients with heart failure

doi: 10.1038/nature15766

This is why our program is built on the foundation of medical supervision and personalization

Taken together, these findings suggest that GLP-1RAs are poised to reshape the therapeutic landscape by integrating metabolic, cardiovascular, renal, hepatic, and potentially neurological benefits

What to Expect During Your First Weeks on GLP-1 Therapy Starting GLP-1 treatment involves a structured titration schedule designed to minimise side effects whilst building therapeutic efficacy